Skip to main content

Want a detailed portfolio tracker?

Erasca (ERAS) P/E (2021 - 2026)

Erasca (ERAS) P/E from Jul 16, 2021 to Jun 2, 2026. The TTM Erasca (ERAS) P/E is -14.65. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Erasca (ERAS)

YearP/EChange
2026-14.65+72.94%
2025-8.47+118.94%
2024-3.87+133.24%
2023-1.66-63.15%
2022-4.50-4.58%
2021-4.72N/A

Comparison Erasca (ERAS) P/E with competitors

Erasca (ERAS) P/E is -14.65.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.70%
ENLVEnlivex Therapeutics Ltd0.15-101.03%
FGENFibroGen Inc0.24-101.64%
TRAWTraws Pharma Inc0.47-103.23%
FBIOFortress Biotech Inc0.71-104.82%
CHRSCoherus Biosciences Inc0.98-106.67%
ORMPOramed Pharmaceuticals Inc1.47-110.05%
AGENAgenus Inc2.05-113.98%
VIVSVivoSim Labs Inc2.54-117.30%
INVAInnoviva Inc3.19-121.76%
CRMDCorMedix Inc3.65-124.88%
ABEOAbeona Therapeutics Inc4.20-128.70%
VXRTVaxart Inc4.26-129.08%
CVACCureVac N.V.4.45-130.34%
SRPTSarepta Therapeutics Inc4.62-131.56%
GLPGGalapagos NV4.86-133.16%
RIGLRigel Pharmaceuticals4.92-133.57%
ZVRAZevra Therapeutics Inc4.97-133.94%
ABUSArbutus Biopharma Corp5.69-138.85%
CGENCompugen Ltd7.38-150.39%
AUPHAurinia Pharmaceuticals Inc9.25-163.13%
ACADAcadia Pharmaceuticals Inc9.59-165.43%
OMEROmeros Corporation9.88-167.45%
PLXProtalix BioTherapeutics Inc9.91-167.62%
SPROSpero Therapeutics Inc10.73-173.26%
ADMAAdma Biologics Inc11.33-177.32%
SVASinovac Biotech Ltd11.44-178.04%
TBPHTheravance Biopharma Inc11.78-180.37%
HRMYHarmony Biosciences Holdings Inc12.18-183.12%
TGTXTG Therapeutics Inc13.18-189.94%
INCYIncyte Corp13.38-191.32%
SABSSAB Biotherapeutics Inc14.06-195.93%
XOMAXOMA Corp14.95-201.99%
REGNRegeneron Pharmaceuticals Inc14.98-202.23%
PBYIPuma Biotechnology Inc15.05-202.71%
EXELExelixis Inc15.79-207.79%
NAGENiagen Bioscience Inc16.35-211.61%
CPRXCatalyst Pharmaceuticals Inc17.34-218.36%
MDXGMimedx Group Inc17.38-218.57%
ARGXArgen X SE23.07-257.45%
HALOHalozyme Therapeutics Inc23.20-258.33%
XOMAOXOMA Corp25.34-272.96%
VRTXVertex Pharmaceuticals Inc25.66-275.08%
XOMAPXOMA Corp25.67-275.18%
CTMXCytomX Therapeutics Inc25.70-275.37%
ASNDAscendis Pharma A/S26.35-279.85%
RPRXRoyalty Pharma plc - Class A27.50-287.63%
SLNOSoleno Therapeutics Inc29.02-298.01%
LGNDLigand Pharmaceuticals Inc - Class B30.19-306.00%
BMRNBiomarin Pharmaceutical Inc37.51-355.96%
APLSApellis Pharmaceuticals Inc39.02-366.29%
KRYSKrystal Biotech Inc39.70-370.91%
GMABGenmab40.20-374.36%
ONCBeiGene Ltd67.03-557.41%
TECHBio-Techne Corp68.59-568.11%
VCELVericel Corp80.63-650.23%
PHARPharming Group N.V.87.74-698.76%
ALNYAlnylam Pharmaceuticals Inc124.93-952.58%
TLXTelix Pharmaceuticals Ltd139.89-1054.65%
CORTCorcept Therapeutics Inc158.39-1180.89%